These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25782174)

  • 21. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H
    Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A seminal finding for prostate cancer?
    Huang J; Witte ON
    N Engl J Med; 2010 Jan; 362(2):175-6. PubMed ID: 20071710
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostate-specific Membrane Antigen-targeted Isotope Therapy: Inherent Challenges Owing to Heterogeneity and Clonal Evolution.
    Sartor O
    Eur Urol; 2024 Mar; 85(3):205-206. PubMed ID: 38176993
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
    Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
    Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will biomarkers save prostate cancer screening?
    Cooperberg MR
    Eur Urol; 2012 Dec; 62(6):962-3; discussion 964-5. PubMed ID: 22749734
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutagenic Factors and Complex Clonal Relationship of Multifocal Urothelial Cell Carcinoma.
    Du Y; Li R; Chen Z; Wang X; Xu T; Bai F
    Eur Urol; 2017 May; 71(5):841-843. PubMed ID: 27743758
    [No Abstract]   [Full Text] [Related]  

  • 28. Computer-assisted three-dimensional analysis of multifocal/multicentric prostate cancer.
    Fujii T; Ishida E; Shimada K; Hirao K; Tanaka N; Fujimoto K; Konishi N
    Cancer Invest; 2014 Aug; 32(7):303-10. PubMed ID: 24827595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of prostate anatomy, histology, and pathology.
    Lee CH; Akin-Olugbade O; Kirschenbaum A
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):565-75, viii-ix. PubMed ID: 21889721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current aspects on morphology and functions of the prostate].
    Aumüller G; Goebel HW; Bacher M; Eicheler W; Rausch U
    Verh Dtsch Ges Pathol; 1993; 77():1-18. PubMed ID: 7511262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.
    Scott LJ; Clarke NW; George NJ; Shanks JH; Testa NG; Lang SH
    Br J Cancer; 2001 May; 84(10):1417-23. PubMed ID: 11355957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression.
    Waters DJ; Bostwick DG
    Anticancer Res; 1997; 17(3A):1467-70. PubMed ID: 9179185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical impact of genetic susceptibility to prostate cancer.
    Bratt O
    Eur Urol; 2014 Sep; 66(3):500-1. PubMed ID: 24702982
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.
    Husbeck B; Nonn L; Peehl DM; Knox SJ
    Prostate; 2006 Feb; 66(2):218-25. PubMed ID: 16173037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.
    Noguchi M; Stamey TA; McNeal JE; Nolley R
    J Urol; 2003 Aug; 170(2 Pt 1):459-63. PubMed ID: 12853799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible immunoprotective and angiogenesis-promoting roles for malignant cell-derived prostasomes: a new paradigm for prostatic cancer?
    Ekdahl KN; Ronquist G; Nilsson B; Babiker AA
    Adv Exp Med Biol; 2006; 586():107-19. PubMed ID: 16893068
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinoid tumor of the prostate].
    Samsonov VA; Kolomiĭtsev SV
    Arkh Patol; 1982; 44(12):60-3. PubMed ID: 7165534
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocrine-paracrine (APUD, neuroendocrine) cells in the normal and pathologic prostate.
    Di Sant'agnese PA
    Bull Assoc Anat (Nancy); 1991 Jun; 75(229):63-7. PubMed ID: 1685682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.